US Capitol Capsule: Another stem cell win for Obama; but Romney, SCOTUS could undo
This article was originally published in Scrip
After the US Court of Appeals for the District of Columbia on 24 August upheld federal funding for human embryonic stem cell (hESC) research and the Obama administration's rules for governing how taxpayer dollars are allocated and used for those activities, National Institutes of Health (NIH) Director Dr Francis Collins expressed confidence it was full speed ahead for the agency in funding and conducting the research.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.